Esophageal cancer has a poor prognosis and high mortality rate across the world. The diagnosis and treatment of esophageal cancer are hindered by the limited knowledge about the pathogenesis mechanisms of esophageal cancer. Esophageal cancer has two major subtypes, squamous and adenocarcinoma. In this work, we proposed a method to select candidate biomarkers of esophageal squamous carcinoma based on the topological differential analysis between the gene–gene interaction networks for esophageal squamous carcinoma and normal cells. We established the gene–gene interaction networks for esophageal squamous carcinoma and normal based on the correlation of genes. For each gene, we firstly calculated and compared five centrality measures, which co...
Background Developments in high‐throughput genomic technologies have led to improved understanding o...
The main goal of Systems Biology research is to reconstruct biological networks for its topological ...
Esophageal cancer (EC) is the eighth most aggressive malignancy and its treatment remains a challeng...
Gene networks have been broadly used to predict gene functions based on guilt by association (GBA) p...
Cancer is a serious disease responsible for many deaths every year in both developed and developing ...
<div><p>Cancer is a serious disease responsible for many deaths every year in both developed and dev...
BackgroundTo evaluate the potential of candidate proteins as diagnostic markers or drug targets in e...
Background: Esophageal adenocarcinoma (EAC) is one of the mostlethal cancers in the world with a ver...
Objective. Esophageal carcinoma (EC) is a frequently common malignancy of gastrointestinal cancer in...
Background. Esophageal cancer is one of the most common cancers worldwide. Dysregulation of genes pl...
Objective. To explore multiscale integrated analysis methods in identifying key regulators of esopha...
Background: The role of cancer stem cells in esophageal squamous cell carcinoma (ESCC) remains uncle...
Abstract Esophageal squamous cell carcinoma (ESCC) is a life-threatening thoracic tumor with a poor ...
Background Esophageal squamous cell carcinoma (ESCC) has a poor prognosis and is one of the deadlies...
Cancer is a heterogeneous disease mainly driven by abnormal gene perturbations in regulatory network...
Background Developments in high‐throughput genomic technologies have led to improved understanding o...
The main goal of Systems Biology research is to reconstruct biological networks for its topological ...
Esophageal cancer (EC) is the eighth most aggressive malignancy and its treatment remains a challeng...
Gene networks have been broadly used to predict gene functions based on guilt by association (GBA) p...
Cancer is a serious disease responsible for many deaths every year in both developed and developing ...
<div><p>Cancer is a serious disease responsible for many deaths every year in both developed and dev...
BackgroundTo evaluate the potential of candidate proteins as diagnostic markers or drug targets in e...
Background: Esophageal adenocarcinoma (EAC) is one of the mostlethal cancers in the world with a ver...
Objective. Esophageal carcinoma (EC) is a frequently common malignancy of gastrointestinal cancer in...
Background. Esophageal cancer is one of the most common cancers worldwide. Dysregulation of genes pl...
Objective. To explore multiscale integrated analysis methods in identifying key regulators of esopha...
Background: The role of cancer stem cells in esophageal squamous cell carcinoma (ESCC) remains uncle...
Abstract Esophageal squamous cell carcinoma (ESCC) is a life-threatening thoracic tumor with a poor ...
Background Esophageal squamous cell carcinoma (ESCC) has a poor prognosis and is one of the deadlies...
Cancer is a heterogeneous disease mainly driven by abnormal gene perturbations in regulatory network...
Background Developments in high‐throughput genomic technologies have led to improved understanding o...
The main goal of Systems Biology research is to reconstruct biological networks for its topological ...
Esophageal cancer (EC) is the eighth most aggressive malignancy and its treatment remains a challeng...